The COVID-19 pandemic: Ongoing Nordic efforts and R&D

The CE marked automated COVID-19 point-of-care test conforms to the requirements of EU IVD directive and ISO 13485 quality standard. The new coronavirus test is available both as part of

The new synthetic paper for finger prick blood tests, developed at KTH Royal Institute of Technology, could provide accurate point-of-care diagnostics for cancer, COVID-19 and other serious diseases. The innovation

The company has submitted an application to the Swedish Medicines Agency for permission to conduct a phase II clinical study of the drug candidate KAND567 in COVID-19 patients. The ultimate

Researchers at Karolinska Institutet are coordinating a multi-national clinical trial that will evaluate the effect of hyperbaric oxygen treatment (HBO) in severe cases of COVID-19. A total of 200 adults

Given the similarity of the Nordic societies, it is interesting to note how differently some of them have reacted to the current COVID-19 crisis, writes Johan Strang, Associate Professor at

The new national test centre, TestCenter Danmark, is anchored at Statens Serum Institute (SSI) and has been established in close collaboration between the Danish state, the Danish regions, the national

Ali Mirazimi, researcher at Karolinska Institutet and Sweden’s National Veterinary Institute (SVA), coordinates one of eight projects provisionally selected among 144 applicants in the EU-financed Innovative Medicines Initiative (IMI). A

The Indian Council for Medical Research (ICMR) has fast tracked the roll out of the global Solidarity Trial launched by the WHO to help find an effective treatment for COVID-19.

NLSDays and NLSInvest 2020 are postponed, and instead merged together with the already-scheduled 2021 events in Malmö on 19-21 April 2021. The ongoing efforts to slow the spread of COVID-19

Icelandic Sidekick has tailored its digital therapeutics service to the needs of those infected with the new coronavirus in the country. With the new app, the country’s healthcare professionals are

VTT Technical Research Centre of Finland has initiated development of a rapid test for the new coronavirus together with MeVac, the joint vaccine research centre of the Hospital District of

Dignitana has announced that the company has obtained an unsecured loan from the Payroll Protection Program (PPP) in the amount of $353,800 USD. The PPP is a $669 billion USD

NLS has asked industry organizations in all the Nordic countries about the situation and the impact of the COVID-19 pandemic. The COVID-19 pandemic has turned societies in the Nordic region,

Pfizer and BioNTech have announced that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The

The program was launched through an open call for proposals, it resulted in 67 funded projects within 9 focus areas and is financed by the Knut and Alice Wallenberg Foundation.

The University of Copenhagen spin-out company Immunitrack is utilizing its cancer vaccine technology to fight COVID-19. Since the company was founded five years ago it has developed a novel type